Inventor
PATEL MAHENDRA R
US30 patents
⚠️ This page may combine multiple inventors who share the name “PATEL MAHENDRA R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PATEL MAHENDRA R
7 patentsUS9603930B2Mar 28, 2017
Liquid bendamustine formulation
PATEL MAHENDRA R9 citations83
US10869848B2Dec 22, 2020
Carmustine pharmaceutical composition
PATEL MAHENDRA R2 citations72
US10342769B2Jul 9, 2019
Carmustine pharmaceutical composition
PATEL MAHENDRA R3 citations72
US10085971B2Oct 2, 2018
Pharmaceutical solution of asenapine for sublingual or buccal use
PATEL MAHENDRA R2 citations72
US10905677B2Feb 2, 2021
Bendamustine solution formulations
PATEL MAHENDRA R0 citations62
US10456418B2Oct 29, 2019
Preparation of pharmaceutical dosage forms containing iron (III) salts
PATEL MAHENDRA R0 citations51
US9475891B2Oct 25, 2016
Process for the preparation of colesevelam hydrochloride
PATEL MAHENDRA R1 citations51
SANDOZ AG
6 patentsUS7939104B2May 10, 2011
Solubility of hydrophobic drugs with a compound having a carboxylic acid moiety
SANDOZ AG51 citations92
US6962924B2Nov 8, 2005
Salt and polymorphs of desloratadine hemifumarate
SANDOZ AG3 citations60
US7727556B2Jun 1, 2010
Solubility of hydrophobic drugs with a compound having a carboxylic acid moiety
SANDOZ AG3 citations57
US7297789B2Nov 20, 2007
Process of preparation of olanzapine form I
SANDOZ AG2 citations54
US7943585B2May 17, 2011
Extended release antibiotic composition
SANDOZ AG0 citations39
US7834176B2Nov 16, 2010
Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
SANDOZ AG0 citations36
GENEVA PHARMACEUTICALS INC
4 patentsUS6693211B2Feb 17, 2004
Chemical process
GENEVA PHARMACEUTICALS INC13 citations76
US6201153B1Mar 13, 2001
Synthesis of midodrine HCI from a novel intermediate 1-(2′,5′-dimethoxyphenyl)-2-azidoethanone
GENEVA PHARMACEUTICALS INC8 citations71
US6458957B1Oct 1, 2002
α,α-dibromo-α-chloro-acetophenones as synthons
GENEVA PHARMACEUTICALS INC3 citations58
US6586598B2Jul 1, 2003
α, α-dibromo-α-chloro-acetophenones as synthons
GENEVA PHARMACEUTICALS INC0 citations48
SQUIBB & SONS INC
3 patentsAprecia Pharmaceuticals LLC
3 patentsUS11383440B2Jul 12, 2022
Three-dimensional printing system and equipment assembly
Aprecia Pharmaceuticals LLC5 citations70
US11278501B2Mar 22, 2022
Method and system for forming a dosage form within a packaging
Aprecia Pharmaceuticals LLC4 citations64
US12202196B2Jan 21, 2025
Three-dimensional printing system and equipment assembly
Aprecia Pharmaceuticals LLC0 citations59